Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.140 | 0.140 | 0.000 |
Stocks | 99.860 | 99.860 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.423 | 20.469 |
Price to Book | 4.454 | 4.472 |
Price to Sales | 1.642 | 2.463 |
Price to Cash Flow | 18.216 | 17.330 |
Dividend Yield | 1.597 | 1.110 |
5 Years Earnings Growth | 10.205 | 10.700 |
Number of long holdings: 159
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly and Co | - | 10.92 | - | - | |
UnitedHealth Group Inc | - | 7.59 | - | - | |
Johnson & Johnson | - | 6.33 | - | - | |
Merck & Co Inc | - | 5.59 | - | - | |
AbbVie Inc | - | 5.34 | - | - | |
Thermo Fisher Scientific Inc | - | 3.73 | - | - | |
Abbott Laboratories | - | 3.27 | - | - | |
Danaher Corp | - | 2.80 | - | - | |
Pfizer | US7170811035 | 2.60 | 27.53 | -0.43% | |
Amgen Inc | - | 2.53 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JNL/Mellon Capital SP 500 Index Fua | 14.67B | 5.86 | 7.53 | 11.83 | ||
JNL/T Rowe Price Capital Appreciati | 13.47B | 4.78 | 5.78 | 9.95 | ||
JNL/WMC Balanced Fund Class A | 9.16B | 5.72 | 3.96 | 7.24 | ||
JNL/Mellon Capital Nasdaq 100 Funda | 8B | 3.70 | 8.17 | 16.67 | ||
JNL Capital Technology Sector A | 6.89B | 15.33 | 16.28 | 20.43 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review